民生健康：“一株促进EGF和EGFR表达的卷曲乳杆菌JYLU-88”取得专利证书

Group 1 - Minsheng Health (SZ 301507, closing price: 15.52 CNY) announced on August 19 that its subsidiary, Minsheng Zhongke Jiayi (Shandong) Bioengineering Co., Ltd., received an invention patent certificate from the National Intellectual Property Administration for a strain of Lactobacillus curvatus JYLU-88 that promotes EGF and EGFR expression [2] - For the fiscal year 2024, Minsheng Health's revenue composition is as follows: vitamin and mineral supplements account for 96.91%, other health products for 1.93%, probiotics for 0.66%, other businesses for 0.39%, and therapeutic drugs for 0.11% [2]